Brief Inhibitory Training for Eating - Intervention (BITE-I)

June 15, 2026 updated by: Tyler B Mason, George Mason University

Inhibitory Control Training for Adolescents

The purpose of this study is to conduct a proof-of-concept intervention of daily inhibitory control (IC) training.

Aim 1 is to examine the feasibility, acceptability, and barriers of an IC training EMI in adolescents' daily life.

Aim 2 is to evaluate the efficacy of IC training for modifying the hypothesized intervention mechanism: food-related IC and eating regulation.

In the study, participants will:

Complete questionnaires and cognitive tasks Receive a short nutrition education Complete three weeks of daily brain games on your phone

Study Overview

Status

Recruiting

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Estimated)

36

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

  • United States
    • Virginia
      • Fairfax, Virginia, United States, 22030
        • Recruiting
        • George Mason University
        • Contact:
          • Tyler Mason

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • 14-17 years old
  • Have overweight or obesity (BMI-z≥85th percentile)
  • Have a smartphone
  • Can read and speak English
  • Interest in improving one's diet.

Exclusion Criteria:

  • Not currently in eating disorder or weight loss treatment or receiving pharmacological/surgical treatment for obesity in the past four weeks
  • Not meeting criteria for atypical anorexia nervosa or bulimia nervosa

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Inhibitory control training
Behavioral: Daily inhibitory control training
Children will first complete a short nutrition education then complete daily 10-minute inhibitroy control training each day for 10 minutes across 3 weeks

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Inhibitory control
Time Frame: 1 month
Go-No/Go Task with food cues
1 month
Eating self-regulation
Time Frame: 1 month
Self-Regulation of Eating Behaviour Questionnaire
1 month

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Binge-eating symptoms
Time Frame: 1 month
Eating Pathology Symptom Inventory
1 month
Diet Quality
Time Frame: 1 month
Mini-EAT
1 month

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

George Mason University

Investigators

  • Principal Investigator: Tyler Mason, PhD, George Mason University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 1, 2026

Primary Completion (Estimated)

February 10, 2027

Study Completion (Estimated)

March 10, 2027

Study Registration Dates

First Submitted

April 6, 2026

First Submitted That Met QC Criteria

May 11, 2026

First Posted (Actual)

May 18, 2026

Study Record Updates

Last Update Posted (Actual)

June 17, 2026

Last Update Submitted That Met QC Criteria

June 15, 2026

Last Verified

June 1, 2026

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • STUDY00001112

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

All IPD collected throughout the trial

IPD Sharing Time Frame

June 2027 for an indefinite time period

IPD Sharing Access Criteria

Anyone

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL
  • ICF

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe